Peter Vestergaard

26.3k total citations
537 papers, 19.4k citations indexed

About

Peter Vestergaard is a scholar working on Orthopedics and Sports Medicine, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Peter Vestergaard has authored 537 papers receiving a total of 19.4k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Orthopedics and Sports Medicine, 147 papers in Endocrinology, Diabetes and Metabolism and 131 papers in Oncology. Recurrent topics in Peter Vestergaard's work include Bone health and osteoporosis research (197 papers), Bone health and treatments (112 papers) and Vitamin D Research Studies (65 papers). Peter Vestergaard is often cited by papers focused on Bone health and osteoporosis research (197 papers), Bone health and treatments (112 papers) and Vitamin D Research Studies (65 papers). Peter Vestergaard collaborates with scholars based in Denmark, Netherlands and United Kingdom. Peter Vestergaard's co-authors include Leif Mosekilde, Lars Rejnmark, Lars Frost, Jakob Starup‐Linde, Lene Heickendorff, Bo Abrahamsen, Frank de Vries, Pia Eiken, Anne Pernille Hermann and Christine Brot and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Peter Vestergaard

512 papers receiving 18.8k citations

Peers

Countries citing papers authored by Peter Vestergaard

Since Specialization

Citations

This map shows the geographic impact of Peter Vestergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vestergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vestergaard more than expected).

Fields of papers citing papers by Peter Vestergaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Vestergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vestergaard. The network helps show where Peter Vestergaard may publish in the future.

Co-authorship network of co-authors of Peter Vestergaard

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Vestergaard. A scholar is included among the top collaborators of Peter Vestergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Vestergaard. Peter Vestergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Symptom-driven co-existence of diabetic autonomic neuropathy, peripheral neuropathy, and painful neuropathy 2025 ·Acta Diabetologica ·Johan Røikjer, (unknown), (unknown), (unknown), Niels Ejskjær, Peter Vestergaard, Christina Brock	0
2	Direct Healthcare Cost of Fractures in Patients With Type 1 Diabetes: A Population-Based Cohort Study in Denmark 2025 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Morten Frost, Andrea M. Burden, Peter Vestergaard, (unknown), Troels Kristensen	1
3	Skin Autofluorescence May Contribute to Prediction of Low Bone Quality in Type 1 Diabetes—A Clinical Cross‐Sectional Study 2025 ·Diabetes/Metabolism Research and Reviews ·(unknown), Peter Vestergaard, Morten Frost, Claus Bogh Juhl, Torben Harsløf	1
4	Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma 2024 ·Pituitary ·(unknown), (unknown), (unknown), Peter Vestergaard, (unknown), Jesper Karmisholt, Hermann L. Müller, Jakob Dal	8
5	Autofluorescence-guided hemithyroidectomy in a low-volume thyroid institution with no experience in parathyroid surgery: randomized clinical trial 2024 ·British journal of surgery ·(unknown), Lars Rolighed, Therese Ovesen, (unknown), Peter Vestergaard, Frédéric Triponez	2
6	Multimorbidity clusters potentially superior to individual diseases for stratifying fracture risk in older people: a nationwide cohort study 2024 ·Age and Ageing ·Thach Tran, Dana Bliuc, Bo Abrahamsen, Weiwen Chen, John A. Eisman, Louise Hansen, Peter Vestergaard, Tuan V. Nguyen, Robert D. Blank	2
7	1357-P: High Plasma Leptin Levels Are Associated with Low Birth Weight and Disease Severity in People with Recently Diagnosed Type 2 Diabetes 2024 ·Diabetes ·(unknown), (unknown), (unknown), Charlotte Brøns, Verena Hirschberg, Torben Hansen, Niels Jessen, Peter Vestergaard, Jens Steen Nielsen, Kurt Højlund, (unknown), Reimar W. Thomsen, Allan Vaag	1
8	The co-existence of peripheral and vestibular neuropathy in diabetes: a cross-sectional study 2023 ·European Archives of Oto-Rhino-Laryngology ·(unknown), (unknown), Niels Ejskjær, Dan Dupont Hougaard, Peter Vestergaard, (unknown), Johan Røikjer	5
9	Sex‐ and Age Group‐Specific Fracture Incidence Rates Trends for Type 1 and 2 Diabetes Mellitus 2023 ·JBMR Plus ·(unknown), (unknown), Peter Vestergaard, Richard Eastell, Andrea M. Burden, Morten Frost	3
10	Site-Specific Fracture Incidence Rates Among Patients With Type 1 Diabetes, Type 2 Diabetes, or Without Diabetes in Denmark (1997–2017) 2023 ·Diabetes Care ·(unknown), (unknown), Peter Vestergaard, Morten Frost, Andrea M. Burden	19
11	The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study 2023 ·British Journal of Haematology ·(unknown), Lars Christian Gormsen, Lasse Hjort Jakobsen, Toby A. Eyre, Marianne Tang Severinsen, Joachim Bæch, Eldad J. Dann, Andrea Knapp, (unknown), Peter Vestergaard, Tarec Christoffer El‐Galaly, Paw Jensen	2
12	Metformin treatment is associated with reduced risk of hypoglycaemia, major adverse cardiovascular events, and all-cause mortality in patients with post-pancreatitis diabetes mellitus: a nationwide cohort study 2023 ·European Journal of Endocrinology ·(unknown), Morten Hasselstrøm Jensen, (unknown), Peter Vestergaard, Filip K. Knop, Asbjørn Mohr Drewes, Søren Schou Olesen	7
13	Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy 2022 ·Blood Advances ·Joachim Bæch, Marianne Tang Severinsen, (unknown), Henrik Frederiksen, Peter Vestergaard, Christian Torp‐Pedersen, Judit Jørgensen, Michael Roost Clausen, Christian Bjørn Poulsen, Peter de Nully Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin E. Smedby, Sandra Eloranta, Lasse Jakobsen, Tarec Christoffer El‐Galaly	2
14	A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment 2022 ·Blood Advances ·Paw Jensen, Lasse Hjort Jakobsen, Martin Bøgsted, Joachim Bæch, Simon Lykkeboe, Marianne Tang Severinsen, Peter Vestergaard, Tarec Christoffer El‐Galaly	7
15	43rd Annual Meeting of the European Thyroid Association. Virtual Conference, September 4–7, 2021 2021 ·European Thyroid Journal ·Stine Linding Andersen, (unknown), Aase Handberg, Annebirthe Bo Hansen, Peter Vestergaard	7
16	Effect of metformin and insulin vs. placebo and insulin on whole body composition in overweight patients with type 2 diabetes: a randomized placebo-controlled trial 2021 ·Osteoporosis International ·(unknown), Thomas Almdal, Peter Vestergaard, Louise Lundby‐Christensen, Trine Welløv Boesgaard, Leif Breum, (unknown), (unknown), Christian Gluud, Bianca Hemmingsen, Hans Perrild, Sten Madsbad, Elisabeth R. Mathiesen, Lise Tarnow, Birger Thorsteinsson, Henrik Vestergaard, Søren S. Lund, Pia Eiken	10
17	The D‐vitamin metabolite 1,25(OH)₂D in serum is associated with disease activity and Anti‐Citrullinated Protein Antibodies in active and treatment naïve, early Rheumatoid Arthritis Patients 2018 ·Scandinavian Journal of Immunology ·(unknown), Kristian Stengaard‐Pedersen, Peter Vestergaard, Mikkel Østergaard, Peter Junker, Merete Lund Hetland, Kim Hørslev‐Petersen, Torkell Ellingsen	18
18	Cost and health care resource use associated with noncompliance with oral bisphosphonate therapy: an analysis using Danish health registries 2016 ·Osteoporosis International ·Jakob Kjellberg, (unknown), Peter Vestergaard, Rikke Ibsen, (unknown), Ankita Modi	11
19	Risk of cardiovascular disease events: The impact of diabetes and anti-diabetic drugs: A nested case-control study 2014 ·Diabetologia ·Michael Gejl, (unknown), (unknown), (unknown), Søren Gregersen, Peter Vestergaard	1
20	FRACTURE RISK IN PATIENTS WITH MUSCULAR DYSTROPHY AND SPINAL MUSCULAR ATROPHY 2001 ·Journal of Rehabilitation Medicine ·Peter Vestergaard	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact